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Background
Myoclonus–dystonia syndrome (MDS) is a relatively rare syndrome 
characterized by the combination of  myoclonus and dystonia, which 
typically presents in childhood.1 There is a broad spectrum of  clinical 
presentations even within a family.2 It is mainly characterized by upper 
trunk myoclonic jerks predominantly in proximal muscles along with 
milder dystonia involving cervical or brachial regions.3–5
The most prominent and disabling clinical presentation is myoclonus.6
The leading causative gene is Epsilon-sarcoglycan (SGCE) on chro-
mosome 7q21–q31, which accounts for 40% of  the MDS cases with 
autosomal dominant inheritance.1,7 Despite the variations of  clinical 
phenotypes in this syndrome,4,5 leg involvement as the presenting symp-
tom is unusual.3–5
Herein we report a case of  MDS with severe leg involvement as the 
initial and most disabling symptom.
Case presentation
A 29-year-old woman came to our clinic for further assessment of  her 
symptoms. Her problem started when she was 3.5-year-old with involun-
tary jerky movements in her right leg mostly during walking and running. 
These movements gradually progressed and affected left leg, upper limbs, 
trunk, and neck. There was mild improvement of  the symptoms with 
Trihexyphenidyl, Clonazepam, and Tetrabenazine. She also found dra-
matic improvement of  the symptoms by taking alcohol. Her parents were 
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Abstract
Background: Myoclonus–dystonia usually presents variable combination of  myoclonus and dystonia mainly affecting the neck and arms, but leg involvement, 
especially as the presenting sign, is not common.
Case report: A 29-year-old lady with a heterozygous mutation in Epsilon-sarcoglycan (SGCE) gene is presented with rapid jerks of  the right leg interfering with 
walking. She has also manifested dystonic posture and jerks of  the trunk and proximal upper limbs.
Discussion: Although it is not typical, leg involvement could be a manifestation of  myoclonus–dystonia either at presentation or during disease progression.
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On examination she was cognitively intact and speech was normal. 
She had prominent myoclonic jerks in the right leg that caused imbal-
ance and impending to fall episodes when she was standing or walking. 
She also had less severe jerks in the neck, trunk, and the arms with dys-
tonic postures in trunk (causing retropulsion) and gait impairment 
(Video 1). The rest of  neurologic examination revealed no abnormality.
Brain MRI was normal. Genetic study revealed heterozygous muta-
tion of  SGCE gene [C.289C>T (P.R, 77)] confirming diagnosis of  
myoclonus–dystonia (DYT-SGCE).
Discussion
MDS is a combination of  dystonia and myoclonus. The disease onset 
is usually in the first or second decade of  life.3,6
Action myoclonus is typically present at disease onset and the most 
disabling symptom, whereas dystonia is the first or associated symptom 
in 20 and 50% of  the patients, respectively.3 Dystonia is mainly cervical 
or brachial and interestingly is not the patients’ main complaint and 
mostly it has been detected only on examination.6 Myoclonus, not dys-
tonia, responds dramatically to alcohol.8,9 The disease courses in SGCE-
mutated patients might be benign and not interfere with a normal 
active life,10 but there are many exceptions even within the same 
family.9,11
In most reported families, the worsening of  myoclonus is the indi-
cator of  disease progression,6 whereas dystonia usually remains sta-
ble during patient’s life.1 There are few reports indicating sexual 
differences in MDS. Affected females may have an earlier onset and 
more probability of  leg involvement in contrast to more common 
involvement of  upper limbs and trunk in males.1,2
The involvement of  lower limbs at disease onset is unusual, but had 
been reported in the literature.3,4,12 In the largest cohort study on MDS 
patients, of  27 patients with SGCE gene mutation, one case (5%) had 
leg myoclonus and eight cases (42%) had leg dystonia at disease onset, 
all of  them presented before 10 years of  age that is similar to our 
patient. Based on this study, Peal et al. categorized the MDS patients 
into three main subgroups: the first group, the most common form 
with predominantly upper body involvement starting before the age of  
10 years; the second group, less common form, with predominant 
lower limb dystonia presenting before the age of  10 years; and the 
final group, with more prominent cervical dystonia, developing after 
the age of  10 years.4
Raymond et al. in 2008 studied 11 families with MDS and reported 
six out of  seven leg-dominant cases were female and the first symptom 
was dystonia except for one case who presented with early-onset 
myoclonus.3
Koukouni et al. reported two sisters with abnormal gait and difficulty 
in standing or walking started at the age of  18 months with progression 
to upper limbs and neck.2
Some authors suggested age as a determining factor in disease topog-
raphy, in other words the earlier disease onset, the more probability of  
lower limb involvement and gait impairment.13,14
Roze et al. studied 41 patients and found 9 patients had lower limb 
dystonia and only in 2 patients it was the most prominent affected 
site.5
In another study, among 38 SGCE mutation carriers, Tezenas et al. 
reported lower limb dystonia and myoclonus in five and eight cases, 
respectively.12
Overall, it is thought that more frequent leg involvement has 
been seen in SGCE mutation carriers in contrast to nonmutation 
carriers.12
In conclusion, clinicians should be aware of  the possibility that, 
although not typical, leg involvement can be a manifestation of  DYT-
SGCE either at presentation or during disease course and contribute to 
a significant gait impairment.
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